A recent study highlights the increased risk of second primary cancers and mortality in patients with idiopathic inflammatory myopathies. This research underscores the need for ongoing monitoring and management strategies in this patient population.
risk of second primary cancer and death in patients with idiopathic inflammatory myopathies
Original title: “Risk of second primary cancer and death in patients with idiopathic inflammatory myopathies.”